Andreas Wicki, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 89,796 shares at $47.63 ($4.3M) on 2018-11-15, disclosed to the SEC on 2018-11-19.
Open-market sale of $4.3M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.63 | 26,089 | $1.2M | 29.1% |
| 2 | $47.63 | 26,089 | $1.2M | 29.1% |
| 3 | $47.64 | 18,809 | $896K | 20.9% |
| 4 | $47.64 | 18,809 | $896K | 21.0% |
| Total | $47.64 avg | 89,796 | $4.3M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |